Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 75, Issue 1, Pages 286-294Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2014-206074
Keywords
-
Categories
Funding
- VA Research Service
- Arthritis Foundation
- NIH [PAG07996, T32 AR06419]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081881] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR064194] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER
- Veterans Affairs [I01BX002234] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Objective AMP-activated protein kinase (AMPK) is metabolic biosensor with anti-inflammatory activities. Gout is commonly associated with excesses in soluble urate and in nutrition, both of which suppress tissue AMPK activity. Gout is driven by macrophage-mediated inflammation transduced partly by NLRP3 inflammasome activation and interleukin (IL)-1 beta release. Hence, we tested the hypothesis that AMPK activation limits monosodium urate (MSU) crystal-induced inflammation. Methods We studied bone marrow-derived macrophages (BMDMs) from AMPK alpha 1 knockout and wild-type mice, and assessed the selective AMPK pharmacological activator A-769662 and a low concentration (10 nM) of colchicine. We examined phosphorylation (activation) of AMPK alpha Thr172, NLRP3 mRNA expression, and caspase-1 cleavage and IL-1 beta maturation using western blot and quantitative RT-PCR approaches. We also assessed subcutaneous murine air pouch inflammatory responses to MSU crystals in vivo. Results MSU crystals suppressed phosphorylation of AMPKa in BMDMs. Knockout of AMPK alpha 1 enhanced, and, conversely, A-769662-inhibited MSU crystal-induced inflammatory responses including IL-1 beta and CXCL1 release in vitro and in vivo. A-769662 promoted AMPK-dependent macrophage anti-inflammatory M2 polarisation and inhibited NLRP3 gene expression, activation of caspase-1 and IL-1 beta. Colchicine, at low concentration (10 nM) achieved in gout flare prophylaxis dosing, promoted phosphorylation of AMPKa and macrophage M2 polarisation, and reduced activation of caspase-1 and release of IL-1 beta and CXCL1 by MSU crystals in BMDMs in vitro. Conclusions AMPK activity limits MSU crystal inflammation in vitro and in vivo, and transduces multiple anti-inflammatory effects of colchicine in macrophages. Targeting increased and sustained AMPK activation in inflammatory cells merits further investigation for enhancing efficacy of prophylaxis and treatment of gouty inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available